Trial Profile
Cardiopulmonary Function Assessment and NO Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2019
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary) ; Sildenafil
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 25 May 2014 New trial record